SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Michael Collins who wrote (3)2/4/1997 11:37:00 AM
From: luis a. garcia   of 1115
 
Michael thank you for a very informative and thoughtful BEAR essay. Two points, one Zovirak which competes with Lidakol announced a new product in trials..or in the works thus raining a bit on Lidaks parade.. while admiting by default their product is patently INFERIOR to Lidakol (Lidakol kicked their but in European trials) and two:More important: The FDA required Lidak to produce the same color and consistency and smell and feel of the product in the placebo. Lidak pulled the bonehead move to try and deactivate active product to use as a placebo. Well how do you do this??? not well obviously. Lidak has been in contact with the FDA and has overcome this hurdle so there is no reason to think the experiment will fail again and some of the stats you keep quoting are based on skewed data from the first test results. Yes it is. Yes it is.....Lidakol should obtain FDA approval in short order. Cold sores yes .. but the product is targeting HERPES.. as therapeutic topical treatments. Already demonstrated equivalence in Europe against Zovirak. (kicked their but)

Also Lidak has 20 mil in cash reserves and additional products in the works and great technology. (Sorry you screwed that too.) Company insiders have been buying like crazy. This is one hard and positive fact you don't address ... while some vote with feet others are putting their pennies where their mouth is.

The stock is speculative but a great buying oportunity, but in no way appears to be a bad investment at these levels.. You should not see lower levels again....the market generally isn't that kind to the cheapo catch up bears that miss the train.....Yuk Yuk.. Michael the glass is half full...have a little faith.

Oh! by the way the INSTITUTIONAL money is going in and there is measured accumulation underway....so the company should shine in high summer...because the stock supply is drying up quickly.

happy trading... please stay on the RIGHT side of this trade Michael and make yourself a little money, that is the LONGGGGGGG side.

regards

luis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext